Breaking News
Sort by:
Date
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Diamyd Medical today announced that Karin Rosén will join the Board of Directors as an […]
Diamyd Medical and Partners are Awarded SEK 40 Million in VINNOVA Funding for the Prevention of Autoimmune Diseases
The Swedish governmental innovation agency VINNOVA provides SEK 40 million in financing for an innovation milieu in […]
Diamyd Medical Secures Precision Medicine Patent for Prevention and Treatment of Autoimmune Diabetes
The European Patent Office has informed Diamyd Medical that the Company’s patent application regarding prevention […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more